Home › Neoplasms by Histologic Type › Texas › Houston
Neoplasms by Histologic Type clinical trials in Houston, TX
4 studies for Neoplasms by Histologic Type are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- The University of Texas M.D. Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
Neoplasms by Histologic Type trials in other cities
- Atlanta, GA5 studies
- Boston, MA5 studies
- Los Angeles, CA4 studies
- Chicago, IL4 studies
- Baldwin Park, CA3 studies
- San Francisco, CA3 studies
- Clifton, NJ3 studies
- New York City, NY3 studies
- St. Louis, MO3 studies
- Dallas, TX3 studies
- Nashville, TN3 studies
- Tampa, FL3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.